Case-control study on colon cancer regarding previous diseases and drug intake

International Journal of Oncology

Volumn 8, Issue 3, 1996, Pages 439-444

  Hardell, Lennart ^a   Fredrikson, Mats ^b   Axelson, Olav ^b  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Colon cancer; Drug intake; Previous diseases; Risk factors

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYDRALAZINE; INDOMETACIN; IRON; METHYLDOPA; PARACETAMOL; SULFONYLUREA; VERAPAMIL;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHOLECYSTECTOMY; COLON CANCER; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; ULCERATIVE COLITIS;

EID: 0029971675     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.8.3.439     Document Type: Article

References (36)

1. Bargen JA: Chronic ulcerative colitis associated with malignant disease. Arch Surg 17: 561-576, 1928.
2. deDombal FT, Watts JMcK, Watkinson G and Goligher JC: Local complications of ulcerative colitis: Strictures, pseudopolypsis, and carcinoma of colon and rectum. Br Med J 1: 1442-1447, 1966.
3. Devroede GJ, Taylor WF, Sauer WG, Jackman RJ and Stickler GB: Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 285: 17-21, 1971.
4. Rutegård J: Ulcerative colitis in an unselected population with special reference to colorectal cancer risk and DNA abnormalities. Umeå University Medical Dissertation, Umeå, Sweden, 1988.
5. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK and Williams CB: Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 31: 800-806, 1990.
6. Greenstein AJ, Sachar DB, Smith H, Janowitz HD and Aufses AH: Patterns of neoplasia in Chrohn's disease and ulcerative colitis. Cancer 46: 403-407, 1980.
7. Giovannucci E, Colditz GA and Stampfer MJ: A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology 105: 130-141, 1993.
8. Sandler RS: Cholecystectomy and colorectal cancer. Gastroenterology 105: 286-288, 1993.
9. Paul J, Gessner F, Wechsler JG, Kuhn K, Orth K and Ditschuneit H: Increased incidence of gallstones and prior cholecystectomy in patients with large bowel cancer. Am J Gastroenterol 87: 1120-1124, 1992.
10. Quigley EMM, Hole DJ and Gillis CR: Gall stones and colon cancer. Am J Gastroenterol 88: 2136-2137, 1993.
11. Janowitz P: Gall stones and colon cancer. Am J Gastroenterol 88: 2137-2138, 1993.
12. Vobecki J, Caro J and Devroede G: A case-control study of risk factors for large bowel carcinoma. Cancer 51: 1958-1963, 1983.
13. Grobost O, Boutron MC, Arveux P, Bedenne L, Chatrenet P and Faivre J: Appendectomy, cholecystectomy, cholelithiasis in relation to colorectal cancer: A retrospective case-control study in the Côte-d'Or (France). Gastroenterol Clin Biol 15: 594-599, 1991.
14. Friedman GD and Fireman BH: Appendectomy, appendicitis, and large bowel cancer. Cancer Res 50: 7549-7551, 1990.
15. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD and Shapiro S: A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83: 355-358, 1991.
16. Thun MJ, Namboodiri M and Heath CW: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593-1596, 1991.
17. Suh O, Mettlin C and Petrelli NJ: Aspirin use, cancer, and polyps of the large bowel. Cancer 72: 1171-1177, 1993.
18. Hardell L: Relation of soft-tissue sarcoma, malignant lymphoma and colon cancer to phenoxy acids, chlorophenols and other agents. Scand J Work Environ Health 7: 119-130, 1981.
19. Axelson O, Flodin M and Hardell L: A comment on the reference series with regard to multiple exposure evaluations in a case-referent study. Scand J Work Environ Health 8: 15-19, 1982.
20. Suadicani P, Hein HO and Gyntelberg F: Is the use of antihypertensives and sedatives a major risk factor for colorectal cancer? Scand J Gastroenterol 28: 475-481, 1993.
21. Fredriksson M, Bengtsson NO, Hardell L and Axelson O: Colon cancer, physical activity, and occupational exposures, a case-control study. Cancer 63: 1838-1842, 1989.
22. Fredrikson M, Hardell L, Bengtsson NO and Axelson O: Colon cancer and dietary habits, a case-control study. Int J Oncol 7: 133-141, 1995.
23. Breslow NE and Day NE: Statistical methods in cancer research. In: The Analysis of Case-Control Studies. Volume 1. IARC Sci Publ No. 32. IARC, Lyon pp133-134, 1980.
24. Giovanucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC and Speizer FE: Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609-614, 1995.
25. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R and Fraumenin JF Jr: Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85: 307-311, 1993.
26. Isomaki HA, Hakulinen T and Joutsenlahti U: Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 31: 691-696, 1978.
27. Marnett LJ: Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575-5589, 1992.
28. Weitz H, Kirschender C, Wiebecke E and Eder M: The effect of cholecystectomy on the induction of colorectal tumours in mice by 1,2-dimethylhydrazine. Res Exp Med 184: 59-65, 1984.
29. Rodriquez PM, Cruz NI, Gonzalez CI and Lopez R: The effect of a high fat diet on the incidence of colonic cancer after cholecystectomy in mice. Cancer 62: 727-729, 1988.
30. Kreger BE, Anderson KM, Schatzkin A and Splansky GL: Serum cholesterol level, body mass index, and the risk of colon cancer. Cancer 70: 1038-1043, 1992.
31. La Vecchia C, D'Avanzo B, Negri E and Franceschi S: History of selected diseases and the risk of colorectal cancer. Eur J Cancer 27: 582-586, 1991.
32. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D and Persson I: Cancer risk in patients with diabetes mellitus. Cancer Cause Control 2: 307-314, 1991.
33. Kaufman DW, Kelly JP, Rosenberg L, Stolley PD, Warshauer ME and Shapiro S: Hydralazine use in relation to cancers of the lung, colon, and rectum. Eur J Clin Pharmacol 36: 259-264, 1989.
34. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Strom BL, Harlap S and Shapiro S: Relation of benzodiazepine use and the risk of selected cancers: Breast, large bowel, malignant melanoma, lung, endometrium, ovary, non-Hodgkin's lymphoma, testis, Hodgkin's disease, thyroid, and liver. Am J Epidemiol 141: 1153-1160, 1995.
35. Stevens RG, Jones DY, Migozzi MC and Taylor PR: Body iron stores and the risk of cancer. New Engl J Med 319: 1047-1052, 1988.
36. Lipkin M: Supplementary dietary calcium and inhibition of colon cancer. Eur J Cancer Prev 2: 83-84, 1993.